UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | M | N | O | P | R | S | T | V | Y | Z
Number of items: 38.

A

Abola, EE; Bairoch, A; Barker, WC; Beck, S; Benson, DA; Berman, H; ... CODATA Task Grp Biological Macromo,; + view all (2000) Quality control in databanks for molecular biology. BIOESSAYS , 22 (11) 1024 - 1034.

Allcock, C; Allen, N; Anaf, G; Apler, A; Austin, MP; Bennett, C; ... others,; + view all (2000) Sections. Australasian Psychiatry , 8 , Article 4.

B

Beck, S; Trowsdale, J; (2000) The human major histocompatibility complex: Lessons from the DNA sequence. ANNU REV GENOM HUM G , 1 117 - 137.

Boshoff, C; (2000) Kaposi's sarcoma herpesvirus: from cell biology to pathogenesis. AIDS , 14 S5 - S5.

C

Chester, KA; Bhatia, J; Boxer, G; Cooke, SP; Flynn, AA; Huhalov, A; ... Begent, RHJ; + view all (2000) Clinical applications of phage-derived sFvs and sFv fusion proteins. DISEASE MARKERS , 16 (1-2) 53 - 62.

Chester, KA; Mayer, A; Bhatia, J; Robson, L; Spencer, DI; Cooke, SP; ... Begent, RH; + view all (2000) Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer. Cancer Chemother Pharmacol , 46 Suppl S8 - 12.

Cirinna, M; Trotta, R; Salomoni, P; Kossev, P; Wasik, M; Perrotti, D; Calabretta, B; (2000) Bcl-2 expression restores the leukemogenic potential of a BCR/ABL mutant defective in transformation. BLOOD , 96 (12) 3915 - 3921.

D

Ding, GR; Yaguchi, H; Yoshida, M; Miyakoshi, J; (2000) Increase in X-ray-induced mutations by exposure to magnetic field (60 Hz, 5 mT) in NF-kappaB-inhibited cells. Biochem Biophys Res Commun , 276 (1) 238 - 243. 10.1006/bbrc.2000.3455.

E

Eisen, T; Boshoff, C; Mak, I; Sapunar, F; Vaughan, MM; Pyle, L; ... Gore, ME; + view all (2000) Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer. BRIT J CANCER , 82 (4) 812 - 817.

Ezoe, S; Matsumura, I; Tanaka, H; Kawasaki, A; Machii, T; Enver, T; Kanakura, K; (2000) GATA-1 inhibits cytokine-dependent growth of hematopoietic cells through the inhibition of STAT3 and AP-1 activities. BLOOD , 96 (11) 680A - 680A.

Ezoe, S; Matsumura, I; Tanaka, H; Kawasaki, A; Machii, T; Enver, T; Kanakura, Y; (2000) GATA-2 down-regulates c-myc and affects cytokine-dependent growth of hematopoietic cells. BLOOD , 96 (11) 285A - 285A.

F

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Dearling, J; Watson, R; ... Begent, RHJ; + view all (2000) A model based approach for the optimisation of radioimmunotherapy through antibody design and radionuclide selection. Cancer Biotherapy and Radiopharmaceuticals , 15 (4 2000)

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Dearling, J; Watson, R; ... Begent, RHJ; + view all (2000) Multiparameter analysis using 3D reconstructions of digital images showing the spatial and temporal distribution of factors influencing radioimmunotherapy. Cancer Biotherapy and Radiopharmaceuticals , 15 (4 2000)

Francis, RJ; Sharma, SK; Sena, L; Springer, C; Green, AJ; Hope-Stone, LD; ... Begent, RHJ; + view all (2000) A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. British Journal of Cancer , 83 43 - ?.

G

Guo, AL; Salomoni, P; Luo, JY; Shih, A; Zhong, S; Gu, W; Pandolfi, PP; (2000) Role of PML in p53-dependent apoptosis. BLOOD , 96 (11) 822A - 822A.

H

Heyworth, CM; May, GE; Dexter, M; Gale, KB; Enver, T; (2000) Lineage programming and re-programming by transcription factor GATA-1. BLOOD , 96 (11) 454A - 454A.

M

Mayer, A; Flynn, AA; Tsiompanou, E; Pedley, RB; Dearling, J; Boden, R; Begent, RHJ; (2000) Radioimmunotherapy is more effective in small tumours due to higher dose and dose rate. British Journal of Cancer , 83 16 - ?.

Mayer, A; Flynn, AA; Tsiompanou, E; Pedley, RB; Dearling, J; Boden, R; Begent, RHJ; (2000) Radioimmunotherapy is more effective in small tumours due to higher dose and dose rate. In: BRIT J CANCER. (pp. 32 - 32). CHURCHILL LIVINGSTONE

Miyakoshi, J; Yoshida, M; Yaguchi, H; Ding, GR; (2000) Exposure to extremely low frequency magnetic fields suppresses x-ray-induced transformation in mouse C3H10T1/2 cells. Biochem Biophys Res Commun , 271 (2) 323 - 327. 10.1006/bbrc.2000.2635.

Mungall, AJ; Beck, S; Cann, HM; Dunham, I; Trowsdale, J; Ziegler, A; (2000) Report of the Fourth International Chromosome 6 Workshop 1999. CYTOGENET CELL GENET , 88 (3-4) 174 - 182.

Mungall, AJ; Beck, S; Cann, HM; Dunham, I; Trowsdale, J; Ziegler, A; (2000) Report of the Fourth International Chromosome 6 Workshop 1999. 10-12 June 1999. Cambridge, UK. Abstracts. Cytogenet Cell Genet , 88 (3-4) 173 - 196.

N

Napier, MP; Sharma, SK; Springer, CJ; Bagshawe, KD; Green, AJ; Martin, J; ... Begent, RH; + view all (2000) Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinoma. Clin Cancer Res , 6 (3) 765 - 772.

Nikitenko, LL; Lloyd, BH; Rudland, PS; Fear, S; Barraclough, R; (2000) Localisation by in situ hybridisation of S100A4 (p9Ka) mRNA in primary human breast tumour specimens. INT J CANCER , 86 (2) 219 - 228.

O

Oksenhendler, E; Meignin, V; Dupin, N; Boshoff, C; Isaacson, PG; Clauvel, JP; (2000) High incidence of non-Hogkin's lymphoma (NHL) in HIV/HHV8 associated Castleman's disease (CD). J ACQ IMMUN DEF SYND , 23 (3) A24 - A24.

Oliveros, JC; Blaschke, C; Herrero, J; Dopazo, J; Valencia, J; (2000) Expression profiles and biological function. In: (Proceedings) Genome Inform Ser Workshop Genome Inform. (pp. 106 - 117).

P

Platt, GM; Cannell, E; Cuomo, ME; Singh, S; Mittnacht, S; (2000) Detection of the human herpesvirus 8-encoded cyclin protein in primary effusion lymphoma-derived cell lines. Virology , 272 (2) 257 - 266. 10.1006/viro.2000.0343.

R

Rubin, E; Mittnacht, S; Ludlow, JW; (2000) Mechanism of pRb activation following mitosis. FASEB JOURNAL , 14 (8) A1544 - A1544.

S

Salomoni, P; Condorelli, F; Sweeney, SM; Calabretta, B; (2000) Versatility of BCR/ABL-expressing leukemic cells in circumventing proapoptotic BAD effects. BLOOD , 96 (2) 676 - 684.

Salomoni, P; Pandolfi, PP; (2000) Role of Daxx in B cell selection and apoptosis by CD40. BLOOD , 96 (11) 569A - +.

Salomoni, P; Pandolfi, PP; (2000) Transcriptional regulation of cellular transformation. NAT MED , 6 (7) 742 - 744.

Stoeber, K; Williams, GH; (2000) A biochemical approach to cancer screening and diagnosis using antibodies against proteins that regulate DNA replication. In: Hospital Healthcare Europe 2000/2001. Campden Publishing Limited: London, UK.

T

Tipping, AJ; Mathew, CG; (2000) Erythropoiesis: Current Clinical Practice: Advances in the Genetics and Biology of Fanconi Anaemia. Hematology , 5 (1) 1 - 13.

Tipping, AJ; Zafirides, G; Mahon, FX; Goldman, JM; Melo, JV; (2000) Response of STI571-resistant cells to other chemotherapeutic drugs and signal transduction inhibitors. BLOOD , 96 (11) 98A - 98A.

Tsuzuki, S; Towatari, M; Saito, H; Enver, T; (2000) Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17) generated PML-RAR alpha oncoprotein. BLOOD CELL MOL DIS , 26 (5) 495 - 495.

V

Volpi, EV; Chevret, E; Jones, T; Vatcheva, R; Williamson, J; Beck, S; ... Sheer, D; + view all (2000) Large-scale chromatin organization of the major histocompatibility complex and other regions of human chromosome 6 and its response to interferon in interphase nuclei. J Cell Sci , 113 ( Pt 9) 1565 - 1576.

Y

Yaguchi, H; Yoshida, M; Ding, GR; Shingu, K; Miyakoshi, J; (2000) Increased chromatid-type chromosomal aberrations in mouse m5S cells exposed to power-line frequency magnetic fields. Int J Radiat Biol , 76 (12) 1677 - 1684.

Z

Zhong, S; Salomoni, P; Pandolfi, PP; (2000) The transcriptional role of PML and the nuclear body. NAT CELL BIOL , 2 (5) E85 - E90.

Ziegler, A; Ehlers, A; Forbes, S; Trowsdale, J; Uchanska-Ziegler, B; Volz, A; ... Beck, S; + view all (2000) Polymorphic olfactory receptor genes and HLA loci constitute extended haplotypes. In: Kasahara, M, (ed.) MAJOR HISTOCOMPATIBILITY COMPLEX. (pp. 110 - 130). SPRINGER-VERLAG TOKYO

This list was generated on Mon Dec 22 21:53:01 2014 GMT.